ARO-HBV Reduces All Measurable Viral Products in Patients with Chronic Hepatitis B Virus Infection
November 10th 2018The first results of a study on the use of monthly RNAi with ARO-HBV in patients with chronic hepatitis B virus infections indicate that the treatment effectively reduced all measurable viral products, including HBsAg.
Read More